Scientists Face a Third Round of Charges by Mexican Government

Nearly three dozen of Mexico’s leading researchers are being accused of money laundering, embezzlement, and organized crime, a move other academics say is politically motivated.

Written byChloe Tenn
| 2 min read
building with flag of Mexico

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: The Supreme Court of Mexico
© ISTOCK.COM, STOCKCAM

A third petition by Mexican prosecutors to convict 31 prominent researchers escalates the conflict between the Mexican government’s National Council of Science and Technology and the Scientific and Technological Consultative Forum, an independent advisory board on which the accused scientists serve. Many of the country’s academics say the charges are unfounded and an act of political persecution, reports Times Higher Education. Judith Mariscal, a telecommunications researcher at the Centro de Investigación y Docencia Económicas, tells the outlet that “Academic freedom is at stake.”

According to The Wall Street Journal, a federal judge twice denied arrest warrants brought forward by Mexico’s attorney general Alejandro Gertz Manero, citing insufficient evidence that the scientists illegally embezzled $12 million in government funds. This time around, charges of money laundering and organized crime were also brought forward. The scientists deny the accusations and state that all spending ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • young woman smiling

    Chloe Tenn is a graduate of North Carolina State University, where she studied neurobiology, English, and forensic science. Fascinated by the intersection of science and society, she has written for organizations such as NC Sea Grant and the Smithsonian. Chloe also works as a freelancer with AZoNetwork, where she ghostwrites content for biotechnology, pharmaceutical, food, energy, and environmental companies. She recently completed her MSc Science Communication from the University of Manchester, where she researched how online communication impacts disease stigma. You can check out more of her work here.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies